Table 3.
Overall risk of bias
| S. no. | Domain | Abdlemotleb et al. (2021) | Aldayari et al. (2019) | Masuda et al. (2011) |
|---|---|---|---|---|
| 1 | A clearly stated aim | 2 | 2 | 0 |
| 2 | Inclusion of consecutive patients | 2 | 2 | 0 |
| 3 | Prospective collection of data | 2 | 2 | 2 |
| 4 | Endpoints appropriate to the aim of the study | 2 | 2 | 0 |
| 5 | Unbiased assessment of the study endpoint | 0 | 0 | 0 |
| 6 | Follow-up period appropriate to the aim of the study | 2 | 2 | 2 |
| 7 | Loss to follow-up <5% | 2 | 2 | 2 |
| 8 | Prospective calculation of the study size | 2 | 2 | 0 |
| Additional criteria for comparative study | ||||
| 9 | An adequate control group | 2 | ||
| 10 | Contemporary groups | 2 | ||
| 11 | Baseline equivalence of groups | 2 | ||
| 12 | Adequate statistical analysis | 2 | ||
| Total score | 22/24 | 14/16 | 6/16 | |